_id
6910532accc777a4e85d550a
Ticker
CORBF
Name
Global Cord Blood Corp
Exchange
OTCMKTS
Address
Bank of China Tower, Central, Hong Kong
Country
USA
Sector
Healthcare
Industry
Diagnostics & Research
Currency
USD
Website
https://www.globalcordbloodcorp.com
Description
Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.
Last Close
0.75
Volume
-
Current Price
0.95
Change
26.66666666666666
Last Updated
2025-11-29T11:45:38.223Z
Image
data:image/webp;base64,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
Ipo Date
2007-05-09T00:00:00.000Z
Market Cap
148645328
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2022-06-30
Revenue
297209000
Cost Of Revenue
41976000
Gross Profit
255233000
Operating Expenses
-15429000
Operating Income
142138000
Interest Expense
2073000
Pretax Income
140065000
Net Income
106798000
Eps
0.04
Dividends Per Share
-
Shares Outstanding
133914711
Income Tax Expense
33267000
EBITDA
142138000
Operating Margin
47.82425835018455
Total Other Income Expense Net
-2073000
Cash
1050744000
Short Term Investments
-
Receivables
25445000
Inventories
7237000
Total Current Assets
1093971000
Property Plant Equipment
75196000
Total Assets
1346288000
Payables
1314000
Short Term Debt
-
Long Term Debt
-
Total Liabilities
575703000
Equity
769693000
Depreciation
-
Change In Working Capital
-
Cash From Operations
-327000
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
-327000
PE
3
PB
2.6016379257704045
ROE
13.875402270775492
ROA
7.932775156578682
FCF
-327000
Fcf Percent
-0.001100235860959796
Piotroski FScore
2
Health Score
64
Deep Value Investing Score
6.5
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
8.5
Garp Investing Score
2.5
Growth Investing Score
1.5
Momentum Investing Score
7
Net Net Investing Score
8
Quality Investing Score
6.5
Value Investing Score
8.5
Quarters > 0 > quarter
2022-06-30
Quarters > 0 > income Statement > revenue
297209000
Quarters > 0 > income Statement > cost Of Revenue
41976000
Quarters > 0 > income Statement > gross Profit
255233000
Quarters > 0 > income Statement > operating Expenses
-15429000
Quarters > 0 > income Statement > operating Income
142138000
Quarters > 0 > income Statement > interest Expense
2073000
Quarters > 0 > income Statement > pretax Income
140065000
Quarters > 0 > income Statement > net Income
106798000
Quarters > 0 > income Statement > eps
0.04
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
2669950000
Quarters > 0 > income Statement > income Tax Expense
33267000
Quarters > 0 > income Statement > EBITDA
142138000
Quarters > 0 > income Statement > operating Margin
47.82425835018455
Quarters > 0 > income Statement > total Other Income Expense Net
-2073000
Quarters > 0 > balance Sheet > cash
1050744000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
25445000
Quarters > 0 > balance Sheet > inventories
7237000
Quarters > 0 > balance Sheet > total Current Assets
1093971000
Quarters > 0 > balance Sheet > property Plant Equipment
75196000
Quarters > 0 > balance Sheet > total Assets
1346288000
Quarters > 0 > balance Sheet > payables
1314000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
575703000
Quarters > 0 > balance Sheet > equity
769693000
Quarters > 0 > cash Flow > net Income
-327000
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-327000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
-327000
Quarters > 0 > ratios > PE
0.04
Quarters > 0 > ratios > PB
2.6016379257704045
Quarters > 0 > ratios > ROE
13.875402270775492
Quarters > 0 > ratios > ROA
7.932775156578682
Quarters > 0 > ratios > FCF
-327000
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
-0.001100235860959796
Quarters > 0 > health Score
64
Quarters > 1 > quarter
2022-03-31
Quarters > 1 > income Statement > revenue
297209000
Quarters > 1 > income Statement > cost Of Revenue
41976000
Quarters > 1 > income Statement > gross Profit
255233000
Quarters > 1 > income Statement > operating Expenses
113095000
Quarters > 1 > income Statement > operating Income
142138000
Quarters > 1 > income Statement > interest Expense
4155000
Quarters > 1 > income Statement > pretax Income
140065000
Quarters > 1 > income Statement > net Income
104716000
Quarters > 1 > income Statement > eps
0.8599999978647007
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
121762791
Quarters > 1 > income Statement > income Tax Expense
33267000
Quarters > 1 > income Statement > EBITDA
156360000
Quarters > 1 > income Statement > operating Margin
47.82425835018455
Quarters > 1 > income Statement > total Other Income Expense Net
-2073000
Quarters > 1 > balance Sheet > cash
6660984000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
161302000
Quarters > 1 > balance Sheet > inventories
45879000
Quarters > 1 > balance Sheet > total Current Assets
6935003000
Quarters > 1 > balance Sheet > property Plant Equipment
476691000
Quarters > 1 > balance Sheet > total Assets
8534525000
Quarters > 1 > balance Sheet > payables
8330000
Quarters > 1 > balance Sheet > short Term Debt
147000
Quarters > 1 > balance Sheet > long Term Debt
0
Quarters > 1 > balance Sheet > total Liabilities
3649553000
Quarters > 1 > balance Sheet > equity
4879316000
Quarters > 1 > cash Flow > net Income
104716000
Quarters > 1 > cash Flow > depreciation
14222000
Quarters > 1 > cash Flow > change In Working Capital
613608000
Quarters > 1 > cash Flow > cash From Operations
162030000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-19635000
Quarters > 1 > cash Flow > cash From Financing
-7729000
Quarters > 1 > cash Flow > net Change In Cash
155773000
Quarters > 1 > ratios > PE
0.8599999978647007
Quarters > 1 > ratios > PB
0.018716167030378848
Quarters > 1 > ratios > ROE
2.146120480821492
Quarters > 1 > ratios > ROA
1.2269692806570958
Quarters > 1 > ratios > FCF
162030000
Quarters > 1 > ratios > Piotroski FScore
4
Quarters > 1 > ratios > fcf Percent
0.5451719160590696
Quarters > 1 > health Score
67
Quarters > 2 > quarter
2021-12-31
Quarters > 2 > income Statement > revenue
317202000
Quarters > 2 > income Statement > cost Of Revenue
47281000
Quarters > 2 > income Statement > gross Profit
269921000
Quarters > 2 > income Statement > operating Expenses
120202000
Quarters > 2 > income Statement > operating Income
149719000
Quarters > 2 > income Statement > interest Expense
8041000
Quarters > 2 > income Statement > pretax Income
159125000
Quarters > 2 > income Statement > net Income
135557000
Quarters > 2 > income Statement > eps
1.1212909086887526
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
120893694
Quarters > 2 > income Statement > income Tax Expense
23568000
Quarters > 2 > income Statement > EBITDA
157760000
Quarters > 2 > income Statement > operating Margin
47.19989155175566
Quarters > 2 > income Statement > total Other Income Expense Net
9406000
Quarters > 2 > balance Sheet > cash
6505014000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
154074000
Quarters > 2 > balance Sheet > inventories
47390000
Quarters > 2 > balance Sheet > total Current Assets
6782199000
Quarters > 2 > balance Sheet > property Plant Equipment
483663000
Quarters > 2 > balance Sheet > total Assets
8397726000
Quarters > 2 > balance Sheet > payables
11674000
Quarters > 2 > balance Sheet > short Term Debt
1695000
Quarters > 2 > balance Sheet > long Term Debt
0
Quarters > 2 > balance Sheet > total Liabilities
3610129000
Quarters > 2 > balance Sheet > equity
4774668000
Quarters > 2 > cash Flow > net Income
134192000
Quarters > 2 > cash Flow > depreciation
8041000
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
-
Quarters > 2 > ratios > PE
1.1212909086887526
Quarters > 2 > ratios > PB
0.01898985866661305
Quarters > 2 > ratios > ROE
2.839087450687671
Quarters > 2 > ratios > ROA
1.6142107994473742
Quarters > 2 > ratios > FCF
-
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
56
Quarters > 3 > quarter
2021-09-30
Quarters > 3 > income Statement > revenue
313670000
Quarters > 3 > income Statement > cost Of Revenue
46209000
Quarters > 3 > income Statement > gross Profit
267461000
Quarters > 3 > income Statement > operating Expenses
107009000
Quarters > 3 > income Statement > operating Income
160452000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
156393000
Quarters > 3 > income Statement > net Income
125736000
Quarters > 3 > income Statement > eps
1.030000003440542
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
122073786
Quarters > 3 > income Statement > income Tax Expense
28251000
Quarters > 3 > income Statement > EBITDA
153987000
Quarters > 3 > income Statement > operating Margin
51.153122708579076
Quarters > 3 > income Statement > total Other Income Expense Net
-12048000
Quarters > 3 > balance Sheet > cash
6390632000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
144667000
Quarters > 3 > balance Sheet > inventories
33821000
Quarters > 3 > balance Sheet > total Current Assets
6648463000
Quarters > 3 > balance Sheet > property Plant Equipment
488403000
Quarters > 3 > balance Sheet > total Assets
8258258000
Quarters > 3 > balance Sheet > payables
13442000
Quarters > 3 > balance Sheet > short Term Debt
1675000
Quarters > 3 > balance Sheet > long Term Debt
0
Quarters > 3 > balance Sheet > total Liabilities
3604854000
Quarters > 3 > balance Sheet > equity
4641840000
Quarters > 3 > cash Flow > net Income
125736000
Quarters > 3 > cash Flow > depreciation
-
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-
Quarters > 3 > cash Flow > net Change In Cash
-
Quarters > 3 > ratios > PE
1.030000003440542
Quarters > 3 > ratios > PB
0.019723932643089807
Quarters > 3 > ratios > ROE
2.708753425365803
Quarters > 3 > ratios > ROA
1.5225487021597048
Quarters > 3 > ratios > FCF
-
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
56
Valuation > metrics > PE
3
Valuation > metrics > PB
2.6016379257704045
Valuation > final Score
100
Valuation > verdict
35.0% Undervalued
Profitability > metrics > ROE
13.875402270775492
Profitability > metrics > ROA
9.762416005543109
Profitability > metrics > Net Margin
0.35933635926233726
Profitability > final Score
87
Profitability > verdict
Adequate
Risk > metrics > Debt Equity
0.7479644481630988
Risk > metrics > Interest Coverage
68.56632899179932
Risk > final Score
88
Risk > verdict
Low
Liquidity > metrics > Current Ratio
832.5502283105022
Liquidity > metrics > Quick Ratio
827.0426179604261
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
90
Prev Valuations > 1
90
Prev Valuations > 2
90
Prev Profitabilities > 0
39
Prev Profitabilities > 1
42
Prev Profitabilities > 2
41
Prev Risks > 0
88
Prev Risks > 1
88
Prev Risks > 2
88
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-16T13:24:47.341Z
Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.
Stock Price
$ 0.00
0% increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AGlobal Cord Blood Faces Ongoing Liquidation Challenges Amid Shareholder Disputes - TipRanks
2/12/2025
Global Cord Blood Faces Ongoing Liquidation Challenges Amid Shareholder Disputes TipRanks
Read more →Showing 2 of 4
(Last Updated 2022-06-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Medium
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
High
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 10.86% of the total shares of Global Cord Blood Corp
1.
Oasis Management Co. Ltd(5.076%)
since
2023/03/31
2.
Renaissance Technologies Corp(1.7538%)
since
2023/03/31
3.
Man Group PLC(1.3451%)
since
2023/03/31
4.
Man GLG Event Driven Alternative IN USD(0.7974%)
since
2023/03/31
5.
BlueCrest Capital Management Ltd.(0.5592%)
since
2023/03/31
6.
Quinn Opportunity Partners LLC(0.2423%)
since
2023/03/31
7.
IsZo Capital Management LP(0.2087%)
since
2023/03/31
8.
Natixis Advisors, LLC.(0.1502%)
since
2023/03/31
9.
Bank of America Corp(0.1314%)
since
2023/03/31
10.
Wealth Invest L&P Dividende Fond(0.1215%)
since
2023/06/30
11.
Wealth Invest L&P Global Value Fond(0.12%)
since
2023/06/30
12.
MW Asset Management MW Optimum CR-P Cap(0.0865%)
since
2022/11/30
13.
Morgan Stanley - Brokerage Accounts(0.065%)
since
2023/03/31
14.
Benjamin F. Edwards & Company, Llc(0.0441%)
since
2023/03/31
15.
Northern Trust Corp(0.0236%)
since
2023/03/31
16.
Parametric International Equity I(0.0221%)
since
2023/04/30
17.
Moneta Group Investment Advisors Inc(0.0195%)
since
2023/03/31
18.
American Century Companies Inc(0.0154%)
since
2023/03/31
19.
Avantis® Emerging Markets Equity ETF(0.0139%)
since
2023/06/30
20.
Susquehanna International Group, LLP(0.01%)
since
2023/03/31
21.
Marshall Wace Asset Management Ltd(0.0092%)
since
2023/03/31
22.
CLARK FINANCIAL SERVICES GROUP INC /BD(0.0092%)
since
2023/03/31
23.
Two Sigma Advisers, LLC(0.0085%)
since
2023/03/31
24.
Citadel Advisors Llc(0.0081%)
since
2023/03/31
25.
Cinvest Azero Global FI(0.0075%)
since
2023/05/31
26.
Base Inv Macro Dynamic EUR(0.0052%)
since
2023/05/31
27.
Northern Small Cap Core K(0.0047%)
since
2023/03/31
28.
UMB Bank NA(0.003%)
since
2023/03/31
29.
Avantis® Emerging Markets Equity Instl(0.0015%)
since
2023/05/31
30.
UBS Group AG(0.0009%)
since
2023/03/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2022-06-30)
(Last Updated 2022-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2022-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2022-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.